BDBM430871 US10550102, Example 5-4
SMILES: Cc1cc(ccc1O[C@H]1CCc2cccc(c12)-c1cccc(n1)-n1ncc(C(O)=O)c1C(F)(F)F)C1CCN(CC(F)(F)F)CC1
InChI Key: InChIKey=COIUJLKQOATJCQ-MHZLTWQESA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guanylate cyclase soluble subunit alpha-1/beta-1 (Homo sapiens (Human)) | BDBM430871![]() (US10550102, Example 5-4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description Chinese hamster ovary (CHO) cells overexpressing soluble guanylate cyclase were generated to test the effect of sGC activators in a cellular context.... | US Patent US10550102 (2020) BindingDB Entry DOI: 10.7270/Q2PC34SQ | |||||||||||
More data for this Ligand-Target Pair |